Arthur F Ryan insider trades

Open-market stock purchases and sales by Arthur F Ryan, Director at Regeneron Pharmaceuticals, Inc, from SEC Form 4 filings since Jan 4, 2010.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +229%.

Recent trades

DateStockTradeValue
Jul 2, 2026REGN Regeneron Pharmaceuticals, IncSold$130K
May 1, 2026REGN Regeneron Pharmaceuticals, IncSold$16.9K
May 1, 2026REGN Regeneron Pharmaceuticals, IncSold$10.6K
May 1, 2026REGN Regeneron Pharmaceuticals, IncSold$9.9K
May 1, 2026REGN Regeneron Pharmaceuticals, IncSold$4.9K
May 1, 2026REGN Regeneron Pharmaceuticals, IncSold$2.8K
May 1, 2026REGN Regeneron Pharmaceuticals, IncSold$4.3K
May 1, 2026REGN Regeneron Pharmaceuticals, IncSold$3.6K
May 1, 2026REGN Regeneron Pharmaceuticals, IncSold$712
May 1, 2026REGN Regeneron Pharmaceuticals, IncSold$1.4K
Apr 1, 2026REGN Regeneron Pharmaceuticals, IncSold$771
Apr 1, 2026REGN Regeneron Pharmaceuticals, IncSold$2.3K
Apr 1, 2026REGN Regeneron Pharmaceuticals, IncSold$10.9K
Apr 1, 2026REGN Regeneron Pharmaceuticals, IncSold$10.1K
Apr 1, 2026REGN Regeneron Pharmaceuticals, IncSold$6.2K
Apr 1, 2026REGN Regeneron Pharmaceuticals, IncSold$7K
Apr 1, 2026REGN Regeneron Pharmaceuticals, IncSold$3.1K
Apr 1, 2026REGN Regeneron Pharmaceuticals, IncSold$31.2K
Mar 2, 2026REGN Regeneron Pharmaceuticals, IncSold$7.8K
Mar 2, 2026REGN Regeneron Pharmaceuticals, IncSold$7.1K
Mar 2, 2026REGN Regeneron Pharmaceuticals, IncSold$8.6K
Mar 2, 2026REGN Regeneron Pharmaceuticals, IncSold$5.5K
Mar 2, 2026REGN Regeneron Pharmaceuticals, IncSold$1.6K
Mar 2, 2026REGN Regeneron Pharmaceuticals, IncSold$15.8K
Mar 2, 2026REGN Regeneron Pharmaceuticals, IncSold$3.9K

Companies traded

  • REGN Regeneron Pharmaceuticals, Inc: 1 buy, 468 sales, last Jul 2, 2026
  • CFG Citizens Financial Group Inc/ri: 1 buy, last Feb 14, 2019
  • UBPS Universal Business Payment Solutions Acquisition Corp: 1 buy, 2 sales, last Dec 28, 2012

Get free alerts when Arthur F Ryan files a new trade →